WHO ICTRP trial
A phase 1, randomized, double-blind, placebo-controlled, single- and…
NL-OMON41908 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON41908 |
|---|---|
| Public title | A phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study evaluating safety and pharmacokinetics of VX-150 including an assessment of the effect of food on the pharmacokinetics of VX-150 in healthy adult subjects. |
| Scientific title | A phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study evaluating safety and pharmacokinetics of VX-150 including an assessment of the effect of food on the pharmacokinetics of VX-150 in healthy adult subjects. - VX-150 SAD/MAD/FE Study |
| Primary sponsor | Vertex Pharmaceuticals Incorporated |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Pijn. Pain.;Pain. |
| Interventions | Group 1: 1 x 25 mg VX 150 or placebo, once 2: 1 x X mg VX 150 or placebo, once 3: 1 x X mg VX 150 or placebo, once 4/7: 1 x X mg VX 150 or placebo en 3 x X mg VX 150 once 5: 1 x X mg VX 150 or placebo, once 6: 1 x X mg VX 150 or placebo… |
| Registration date | Jan 26, 2015 |
| Target size | 96 |
| Secondary IDs | 2014-002924-29;NL52002.056.15 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: